Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Onchilles Pharma logo — Developing drug candidates that have the potential to be bro...

Onchilles Pharma

Developing drug candidates that have the potential to be broadly effective against a wide range of cancers.

Founded 2017 United States San Diego, United States 10 employees Series B Total: $39.15M Biopharma, Biotechnology +1

General Information

Company Name Onchilles Pharma
Founded Year 2017
Location United States San Diego, United States
Founders / Decision Makers
Team member
Employees 10
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series B
Business Model B2B, B2D
Revenue Model Licensing, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Onchilles Pharma. To contact Onchilles Pharma, visit onchillespharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Onchilles Pharma compare?

A PDF of Onchilles Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Onchilles Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Onchilles Pharma

Onchilles Pharma, founded in 2017, is a private biotech firm headquartered in the United States at the Alexandria GradLabs in San Diego. Specializing in the Biopharma, Biotechnology, and Pharmaceutical industries, the company is focused on developing drug candidates with the slogan: "Developing drug candidates that have the potential to be broadly effective against a wide range of cancers."

The company emerged from groundbreaking research that uncovered a novel neutrophil pathway capable of selectively and comprehensively killing cancer cells. This pioneering research supports Onchilles Pharma’s pipeline of first-in-class drugs exhibiting broad efficacy against various cancers.

On 01 November 2025, Onchilles secured a $25.00M Series B investment, demonstrating strong investor confidence. Key investors included LYZZ CAPITAL, InVivium Capital, Lincoln Park Capital Fund, and Kennedy Lewis Investment Management LLC.

Business keywords: cancer therapeutics, biotech innovation, first-in-class biologics, neutrophil pathway research, oncology drug development, selective cancer cell targeting, non-toxic cancer treatment, San Diego biotech, Alexandria GradLabs, private biotech company, broad cancer effectiveness, biologics therapies, cancer cell cytotoxicity, novel pharmaceutical pathways, drug candidate pipeline

Services & Products

Drug discovery and development
Cancer-selective killing therapies
Clinical trial advancement

Target Customers

Healthcare providers Cancer treatment centers Oncologists Pharmaceutical partners

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $25.00M 4
LYZZ CAPITAL InVivium Capital Lincoln Park Capital Fund
LYZZ CAPITAL, InVivium Capital +2
01 Nov 2025
Series A $7.00M 2
The University of Chicago LYZZ CAPITAL
The University of Chicago, LYZZ CAPITAL
01 Jun 2021
Series A $7.00M 1
LYZZ CAPITAL
LYZZ CAPITAL
01 Jul 2020
Grant $150.00K 1
George Schultz Innovation Fund
George Schultz Innovation Fund
01 Dec 2017
Spinout Undisclosed 1
The University of Chicago
The University of Chicago
01 Jan 2017

Onchilles Pharma Alternatives & Competitors

View All Alternatives
Onchilles Pharma vs
Maipl Therapeutics, Inc.
Maipl Therapeutics, Inc. United States

#endometriosis #IPF #infertility #pre-term birth #fibrosis

Seed
5 employees
Biotechnology, Pharmaceutical
Onchilles Pharma vs
858 Therapeutics
858 Therapeutics United States

Discovering innovative small molecule therapeutics for the treatment of cancer

Venture round
30 employees
Biotechnology, Health Care
Onchilles Pharma vs
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. United States

Focused on harnessing the immune system to achieve deep and durable clinical responses to improve th...

Post-IPO Equity
96 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Onchilles Pharma

Developing drug candidates that have the potential to be broadly effective against a wide range of cancers.
Onchilles Pharma was founded in 2017.
Onchilles Pharma is headquartered in San Diego, United States.
Onchilles Pharma operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on cancer therapeutics, biotech innovation, first-in-class biologics and neutrophil pathway research. Its customers include Healthcare providers, Cancer treatment centers and Oncologists.
Onchilles Pharma has a B2B and B2D business model. Its revenue comes from Licensing and Product Sales.
Onchilles Pharma has approximately 10 employees.
Onchilles Pharma has completed 5 funding rounds, raising a total of $39.15M. The latest funding stage is Series B.
Onchilles Pharma offers: Drug discovery and development, Cancer-selective killing therapies, Clinical trial advancement.
Top alternatives and competitors to Onchilles Pharma include Maipl Therapeutics, Inc., 858 Therapeutics, Xilio Therapeutics, Inc., Alterome Therapeutics, Inc, Glycyx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Onchilles Pharma and Maipl Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Onchilles Pharma, https://bouncewatch.com/company/onchilles-pharma, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes